جست‌وجوی استاد و پژوهشگر

Taiwo Oluwakemi Adubiمشاهده پروفایل

مدرس

• Parasitology
• Neglected Tropical Diseases
• Epidemiology
• +۵ مورد دیگر

Taiwo Oluwakemi Adubi is a Lecturer in the Department of Zoology, Faculty of Science at the University of Lagos, Nigeria, with continuous service since 2010. She progressed from Assistant Lecturer (2010-2015) to Lecturer II (2015-2023) and currently holds the position of Lecturer I (2023-present). Her academic foundation includes BSc (1997), MSc (1999), and PhD (2016) degrees in Zoology, all obtained from the University of Lagos. Educational background: BSc in Zoology, University of Lagos (February 1997) MSc in Zoology, University of Lagos (July 1999) PhD in Zoology, University of Lagos (October 2016) Dr. Adubi specializes in parasitic infections among vulnerable populations, particularly school-aged children in rural Nigeria. Her research integrates molecular biology, diagnostics, and bioinformatics to address neglected tropical diseases (NTDs), with emphasis on schistosomiasis and soil-transmitted helminths. She pioneers implementation research to bridge intervention gaps through community-NGO-government partnerships, focusing on context-specific drug discovery and diagnostic tools for African settings. Her work increasingly incorporates computational approaches to combat drug resistance in NTD treatments. Analysis of her 2011-2025 publications reveals consistent field epidemiological studies across Nigerian states (Ogun, Plateau, Katsina), evolving from basic parasite detection to molecular characterization and clinical outcomes. Key trends include methodological shifts toward PCR-based diagnostics, expansion into female genital schistosomiasis, and growing emphasis on community-based intervention strategies. Her research maintains strong Nigeria-specific focus while addressing globally relevant NTD challenges. Professional engagement: Course Advisor, Department of Zoology (2019-2024) Member, Royal Society of Tropical Medicine and Hygiene (2021-2023) National Treasurer, Parasitology and Public Health Society of Nigeria (2015-2021) Member, Parasitology and Public Health Society of Nigeria (1999-present) Vice Chancellor Representative, Caleb University Disciplinary Committee (2016-2019) Dr. Adubi actively seeks international grants to advance her research vision, emphasizing mentorship-driven team science to tackle critical NTD questions. She has contributed to national health initiatives including malaria case management training (Society for Family Health, 2013) and Long-Lasting Insecticide Nets campaigns (National Malaria Control Programme, 2009), demonstrating commitment to translating research into public health action through interdisciplinary collaboration.

Waseem Asgharمشاهده پروفایل

استاد

• Biosensors
• Microfluidics
• Point-of-Care Diagnostics
• +۳ مورد دیگر

Dr. Waseem Asghar serves as Associate Chair and Professor in both the Department of Electrical Engineering and Computer Science and Department of Biomedical Engineering at Florida Atlantic University. Leading the Micro and Nanotechnology in Medicine Lab, his research develops revolutionary point-of-care diagnostic platforms for HIV, Zika, Ebola, cancer, and fertility applications. His work bridges engineering innovation with clinical impact, focusing on disposable, refrigeration-free technologies deployable in resource-limited settings worldwide. Dr. Asghar earned his Ph.D. from the University of Texas at Arlington and previously held a position at Harvard University before joining FAU. His educational background underpins his interdisciplinary approach to biomedical device development. His research program centers on microfluidics and biosensors for decentralized diagnostics. Key projects include NIH-funded CD4+ T cell counters for HIV monitoring, smartphone-integrated Zika detectors for airport screening, and self-regulating CSF shunt devices developed with Boca Raton Regional Hospital. The lab specializes in paper-based microfluidics and flexible substrates that enable multiplexed biotarget detection without complex instrumentation. Recent work emphasizes eliminating cold-chain requirements for viral load testing and creating home-based semen analysis tools. Dr. Asghar's publication portfolio demonstrates consistent high-impact contributions in point-of-care diagnostics. His work spans infectious disease detection (Ebola, HIV, Zika), cancer diagnostics (circulating tumor cells), and reproductive health (sperm analysis), frequently appearing in journals like Nature Scientific Reports, Biotechnology Advances, and ACS Biomaterials Science & Engineering. The research shows a clear trajectory toward field-deployable, low-cost solutions validated in clinical environments. His scientific recognition includes: NSF CAREER Award (2020) FAU Researcher of the Year (2020, 2023) ASEE SE New Faculty Researcher Award (2020) Engineers’ Council Outstanding STEM Educator Award (2018) Humanity in Science Award (2016) FAU Mentoring Award (2015) Dr. Asghar actively mentors PhD and Master's students, with recent graduates including Amy Makler (2023), Kabir and Bob (2021), and Mazhar Sher (2020). His NIH-funded projects provide robust research support, while industry collaborations ensure real-world relevance. Students regularly win awards for poster presentations and leadership, reflecting the lab's emphasis on professional development alongside technical excellence. The Micro and Nanotechnology in Medicine Lab operates as a dynamic interdisciplinary hub where electrical engineers, biomedical researchers, and computer scientists collaborate. The team focuses on translating lab innovations into deployable solutions, evidenced by media coverage from ABC, NPR, and Cheddar News. Current efforts target commercialization of Zika detection devices and HIV viral load assays, with strong emphasis on global health equity through accessible diagnostics.

Nicolas ARGYمشاهده پروفایل

مدرس

• Infectious Diseases
• Parasitology
• Malaria Research
• +۳ مورد دیگر

Nicolas ARGY serves as a University Lecturer and Hospital Practitioner at the Faculty of Pharmacy, University of Paris, with research email nicolas.argy@gmail.com. His dual academic-clinical role spans molecular diagnostics development and hospital-based infectious disease management. His research concentrates on malaria pathogenesis (particularly cerebral malaria), molecular diagnostic validation for parasitic infections, and extracellular vesicle roles in disease mechanisms. Key projects include SMMALA (Smartphone Malaria) for point-of-care diagnostics and PEXCELV investigating vesicle-mediated biomarkers in cerebral malaria. Clinical interests encompass complex presentations of toxoplasmosis, microsporidiosis, and fungal infections in immunocompromised hosts. Analysis of his 2020-2022 publications reveals consistent focus on diagnostic accuracy studies (comparing PCR/qPCR/LAMP platforms), malaria complications (kidney injury, anemia), and pathogenesis mechanisms using genomic approaches. His work bridges laboratory science and clinical practice through hospital-based research. He currently leads the SMMALA and PEXCELV projects, indicating active grant funding for smartphone-based diagnostics and extracellular vesicle research. His hospital practitioner role facilitates clinical sample access and translational research, though specific student supervision details aren't provided. International collaborations are evident through Benin-based malaria studies. The research environment emphasizes diagnostic innovation for resource-limited settings and molecular investigation of severe malaria complications, with strong connections between the Faculty of Pharmacy laboratory and clinical hospital settings.

• Epidemiology
• Biotechnology
• Public Health
• +۵ مورد دیگر

Professor Vincenzo Romano Spica serves as Full Professor of General and Applied Hygiene at the University of Rome Foro Italico's Department of Human Motor Sciences and Health, where he directs the Laboratory of Epidemiology and Biotechnology. He maintains significant external roles including Scientific Responsible for ISS Working Groups on thermal waters and pool safety, Scientific Direction for Federterme and Forum Piscine, and collaborations with INAIL and research startups. His research integrates Epidemiology , Biotechnology , and Public Health with specialized focus on sports facility hygiene , water safety (pools/thermal baths), and molecular prevention strategies for infectious/chronic diseases. Key methodologies include human microbiota analysis, biomarker development, and public health guideline formulation, all emphasizing practical community health applications through interdisciplinary synergy. Recent publication trends demonstrate concentrated pandemic-response research (2020-2021) spanning virological transmission monitoring, nutritional interventions for disease severity, and behavioral epidemiology of lockdown effects. These works consistently bridge laboratory science with public health implementation through high-impact collaborations. Active research funding includes PNRR projects (RTDA, Doctorate programs) and 'Smart Money' initiatives, with institutional partnerships spanning ISS, INAIL, Federterme, and Forum Piscine. His laboratory provides evidence-based tools for environmental safety and health promotion directly adopted by national health authorities. The Laboratory of Epidemiology and Biotechnology operates as an interdisciplinary hub where young researchers develop translational solutions for sports hygiene, water safety, and pandemic preparedness. Its unique integration of molecular biotechnology with public health practice produces actionable protocols for community health enhancement, particularly in recreational environments and sports facilities.

• Molecular Genetics
• Genome Evolution
• Mobile Genetic Elements
• +۵ مورد دیگر

Ruslan Kalendar is a Professor in Biology with 143 publications and prominent editorial leadership, serving as Specialty Chief Editor for Technical Advances in Plant Science at Frontiers in Plant Science and Review Editor for Genomics of Plants and the Phytoecosystem. His research bridges molecular genetics, genome evolution, and practical applications in plant science and medical diagnostics, supported by an international collaborative network spanning Kazakhstan, Russia, and Europe. His primary research focuses on evolutionary processes governing mobile genetic elements in eukaryotic genomes, with significant extensions into plant genomics and bioinformatics. Recent work analyzes nucleotide polymorphism in Pinus sylvestris populations, identifies drought-resistance SNPs in spruce hybrids, and develops computational tools for PCR design. This interdisciplinary approach connects fundamental genome dynamics to agricultural resilience and molecular diagnostic innovation. Publication trends reveal strong integration of computational and experimental methods, particularly in 2024-2025 outputs. Key themes include in silico PCR optimization for nucleic acid amplification, whole-genome sequencing applications in medical genetics (epilepsy disorder case reports), and environmental genomics for plant biomonitoring/bioremediation. His editorial contributions further amplify impact in plant science methodology and genomic adaptation research. Professor Kalendar actively cultivates scientific community engagement through editorial leadership and collaborative networks. His 197 followed researchers and 74 followers reflect substantial academic influence, with co-authorship patterns indicating particularly strong ties to Kazakh institutions like Nazarbayev University. This connectivity facilitates cross-disciplinary research in genome evolution and its practical applications.

Gülnur Tarhanمشاهده پروفایل

استاد

• Microbiology
• Tuberculosis Research
• Mycobacterium tuberculosis
• +۷ مورد دیگر

Gülnur Tarhan is a Professor at Adiyaman University, Faculty of Medicine, Department of Basic Medical Sciences. With a distinguished career spanning multiple decades, she has established herself as a leading expert in microbiology and tuberculosis research in Turkey. Her research interests focus on microbiology , particularly tuberculosis and drug resistance mechanisms . She has conducted extensive work on molecular typing methods for Mycobacterium tuberculosis, diagnostic techniques for infectious diseases, and nontuberculous mycobacteria. Her laboratory research integrates molecular biology techniques with clinical applications to improve tuberculosis diagnosis and treatment. Professor Tarhan has published numerous articles in the last five years, with research spanning molecular epidemiology of tuberculosis across different regions of Turkey, drug susceptibility testing methods, and identification of resistance mechanisms. Her work has practical implications for public health and clinical practice in infectious disease management. As an educator, she teaches Pharmacology, Microbiology and Parasitology, Immunology, and Medical Microbiology across various levels of medical education. Her commitment to education extends to authoring and translating important microbiology textbooks that serve Turkish medical students and professionals. Professor Tarhan has collaborated with national institutions including the Ministry of Health and Refik Saydam Hygiene Center, as well as international partners through the Japan International Cooperation Agency (JICA) Infectious Disease Control Project. Her work bridges laboratory research, clinical practice, and public health policy in infectious disease control.

• Medical diagnostics
• Molecular biology
• Bioseparations
• +۷ مورد دیگر

Dr. Richard Willson is a Distinguished Visiting Professor in Biotechnology Engineering at Tecnológico de Monterrey, affiliated with both the Obesity Research Institute and the School of Medicine and Health Sciences. He simultaneously holds the prestigious Huffington-Woestemeyer Professorship of Chemical and Biomolecular Engineering and of Biochemistry at the University of Houston. His extensive academic career includes significant roles as co-principal investigator for the FDA's Southwest-Midwest National Pediatric Device Innovation Consortium (SWPDC), a long-standing affiliate in Baylor College of Medicine's Quantitative and Computational Biology program since 2008, and a distinguished senior affiliate in the Cancer program at the Houston Methodist Research Institute since 2007. Dr. Willson's research focuses on developing innovative diagnostics for infectious diseases and metabolic disorders through biomolecular recognition using monoclonal antibodies and aptamers. His laboratory specializes in expression systems, mutagenesis, fluorescence anisotropy kinetics, and titration calorimetry. Recent work emphasizes antibody purification, ultra-sensitive lateral flow immunoassays for home-based detection, and computer technology applications for differentiating viruses from human DNA. His expertise in nucleic acid purification led to his selection for Moderna's founding Technical Advisory Board in 2012, where he contributed to the foundational work that later enabled the development of mRNA-based COVID-19 vaccines. Medical diagnostics Molecular biology Bioseparations Immunochromatographic diagnostics Process analytical technology Infectious disease diagnostics Metabolic disorder diagnostics Dr. Willson's educational background includes a PhD in Chemical Engineering from MIT, a Master of Science in Chemical Engineering from Caltech, and postdoctoral training in Biology at MIT. His research bridges engineering principles with clinical applications to address significant healthcare challenges through innovative diagnostic solutions.

Dimitrios Evangelopoulosمشاهده پروفایل

مدرس

• Antimicrobial resistance
• Tuberculosis research
• Drug discovery
• +۶ مورد دیگر

Dimitrios Evangelopoulos is a Lecturer in Microbiology at University College London's Department of Microbial Diseases within the UCL Eastman Dental Institute. He holds a PhD in Molecular Microbiology from Birkbeck, University of London and a B.Sc. in Molecular Biology and Genetics from Democritus University of Thrace, Greece. His academic career includes significant research positions at the Francis Crick Institute and UCL's Centre for Clinical Microbiology as part of the European PreDiCT-TB consortium. His educational background includes: PhD in Molecular Microbiology, Birkbeck, University of London (2011) B.Sc. in Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupoli, Greece (2006) Dr. Evangelopoulos' research primarily focuses on antimicrobial resistance mechanisms in tuberculosis, with particular emphasis on drug discovery and development of molecular biomarkers for bacterial load quantification. His work bridges fundamental microbiology with clinical applications, exploring transcriptomic signatures of drug action in Mycobacterium tuberculosis and investigating novel antibiotic strategies. He has expanded his expertise to include SARS-CoV-2 diagnostics during the recent pandemic, demonstrating adaptability in addressing emerging infectious disease challenges. Analysis of his publication record reveals a strong focus on tuberculosis drug discovery and resistance mechanisms, with recent expansion into diagnostic methodologies and pandemic response. His work demonstrates an interdisciplinary approach combining microbiology, biochemistry, and molecular biology to address antimicrobial resistance challenges. The publications show consistent progression from basic research on mycobacterial drug targets to translational applications in drug development and diagnostic tools. Professional memberships include: Full member of Microbiology Society (since 2011) Elected member of Acid Fast Club (since 2012) Member of British Society for Antimicrobial Chemotherapy (since 2015) Dr. Evangelopoulos actively supervises research degrees and taught course research projects, with teaching responsibilities spanning undergraduate and postgraduate programs. His teaching portfolio includes modules on medical bacteriology, drug discovery, and research methods. His research program, established at UCL Eastman Dental Institute in 2019, continues to investigate antimicrobial resistance while contributing to collaborative drug discovery projects. He leads research within the Department of Microbial Diseases, focusing on antimicrobial resistance mechanisms and drug discovery approaches against Mycobacterium tuberculosis. His laboratory applies interdisciplinary methods including metabolomics, transcriptomics, and molecular biology techniques to investigate novel antibiotic strategies and resistance mechanisms.

• Medical Microbiology
• Antimicrobial Resistance
• Antifungal Agents
• +۳ مورد دیگر

Ali Öztürk is an Associate Professor at Niğde Ömer Halisdemir University's Faculty of Medicine, specializing in the Department of Medical Microbiology. He holds a Doctorate from Gazi University (2010–2016) and a Master's from the same institution (2008–2010), with a Bachelor's in Biology from the University of Baghdad (2001–2006). His research centers on antimicrobial resistance, antifungal agents, biofilm disruption, and diagnostic methods in clinical microbiology. Öztürk's work includes significant projects such as the characterization of carbapenem-resistant Acinetobacter baumannii and the efficacy of antimicrobial photodynamic therapy. He leads the 'Multicenter Türkiye Saprochaete Study' and collaborates on EU-funded initiatives like BIOHYPO. He advises PhD candidate DHUHA FOUAD ALI AL SAMMARRAIE and has secured grants from TÜBİTAK and Higher Education Institutions. His recent publications (2021–2025) focus on antifungal compounds, disinfectant efficacy, and COVID-19 diagnostics, reflecting expertise in molecular microbiology and medicinal chemistry. Administrative roles include departmental leadership and committee memberships at Niğde Ömer Halisdemir University.

• Virology
• Bacteriology
• Immunology
• +۵ مورد دیگر

Uffe Vest Schneider serves as an Associate Professor and Part-time lecturer in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. His research spans virology and bacteriology with significant contributions to understanding viral pathogens, transmission dynamics, and immune responses. Dr. Schneider's research program focuses on critical areas of viral pathogenesis and public health. His work examines viral evolution mechanisms, particularly in hepatitis C virus hypervariable regions and SARS-CoV-2 variants, with emphasis on immune evasion strategies. He has developed innovative surveillance methodologies, including community-based self-sampling systems for monitoring respiratory viruses in Denmark. His bacteriology research complements his virology work, providing a comprehensive understanding of microbial pathogens. His publications demonstrate expertise across molecular virology, clinical epidemiology, and public health interventions. Analysis of Dr. Schneider's publication record reveals a strategic research trajectory addressing emerging viral threats. His work spans from fundamental molecular studies of viral evolution to population-level investigations of disease transmission and vaccine effectiveness. The 2025 publications on mpox transmission scenarios and hepatitis C virus mechanisms represent continuation of his focus on viral evolution, while the community-based surveillance system demonstrates practical application of his research to public health infrastructure. His 2023 SARS-CoV-2 studies covered the full spectrum from diagnostics to clinical outcomes, showcasing methodological diversity and interdisciplinary approach. Dr. Schneider's research has achieved significant visibility, with multiple publications being covered by news outlets, shared extensively on social media platforms (including thousands of X/Twitter mentions), and widely read on academic networks like Mendeley. His collaborative approach is evident in the large author lists on many publications, indicating strong national and international research partnerships. Based at Blegdamsvej 3B in Copenhagen, Dr. Schneider operates within one of Europe's leading institutions for medical research. His dual appointment structure suggests an intentional balance between research-intensive work as Associate Professor and teaching responsibilities as Part-time lecturer, contributing to both knowledge generation and academic training in microbiology and immunology.

Eric J. Mooreمشاهده پروفایل

استاد

• Head and Neck Cancer
• Parotid and Salivary Gland Surgery
• Microvascular Reconstructive Surgery
• +۴ مورد دیگر

Dr. Eric J. Moore is a Professor of Otolaryngology and serves as the Chair of the Department of Otolaryngology-Head and Neck Surgery at Mayo Clinic. He holds multiple consultative appointments across the institution, including in the Division of Oral Diagnosis and Oral and Maxillofacial Surgery (Department of Surgery), Department of Neurosurgery, and Department of Pediatric and Adolescent Medicine. As a leading head and neck cancer surgeon and facial plastic and reconstructive surgeon, Dr. Moore specializes in complex tumor removal and reconstructive surgery. Dr. Moore's research focuses on improving patient outcomes through innovative surgical techniques and treatment strategies. His primary research areas include parotid gland surgery, transoral robotic surgery (where he assisted in the original FDA approval process), deintensification strategies for HPV-related oropharyngeal cancer, and microvascular reconstruction using computer modeling and 3D printing technology. His research aims to minimize incisions, maintain normal tissue, and improve reconstructions to restore patients' appearance and function after cancer surgery. His publication record demonstrates consistent scholarly output with 218 publications spanning from 1999 to 2025, with recent focus on HPV-related oropharyngeal cancer, liquid biopsy techniques, and surgical innovations. Analysis of his recent publications shows a strong emphasis on translational research that bridges laboratory findings with clinical applications, particularly in the areas of precision oncology and surgical innovation. Castle Connolly Top Doctors (2011-2021) Distinguished Clinician Award (2012) Gunnar Holmgren Award (2021) Joseph H. Ogura Memorial Lecturer Award (2017) Academy of Educational Excellence Fellow (2020) Multiple Teacher of the Year awards Distinguished Humanitarian Award (2007) As an educator, Dr. Moore provides mentorship to residents and fellows, with numerous teaching awards recognizing his excellence in medical education. His humanitarian work includes leading and participating in surgical missions worldwide. His clinical practice focuses on head and neck cancer treatment with particular expertise in robotic surgery, microvascular reconstruction, and treatment of HPV-related cancers with minimal morbidity. Dr. Moore's laboratory and clinical research activities are centered at the Mayo Clinic Comprehensive Cancer Center and the Head and Neck Cancer Center, where he leads research efforts to improve surgical outcomes and develop innovative treatment approaches for head and neck cancer patients.

Paolo M. Fortinaمشاهده پروفایل

استاد

• Genomics
• Molecular Diagnostics
• Cancer Research
• +۴ مورد دیگر

Paolo M. Fortina, MD, PhD, is a Professor at the College of Life Sciences in Philadelphia, PA. His research bridges genomics, molecular diagnostics, and microfabrication technology to study disease mechanisms and develop clinical solutions. Key focuses include genetic disorders (thalassemia, deafness, cystic fibrosis), cancer pathways (retinoblastoma, neuroblastoma), and platelet transcriptomics analyzed via next-generation sequencing. His work integrates engineering and biology, evidenced by collaborations with biotech firms (Hitachi, Affymetrix) to design microfluidic chips for PCR, SNP typing, and array-based diagnostics. Current projects explore non-coding RNAs and exome sequencing in X-linked mental retardation and thrombocytopenia. Publications demonstrate expertise in: Cancer biology (e.g., retinoblastoma DNA repair mechanisms) Transcriptomics (dermatology, exosome miRNAs) Immunology (T-cell plasticity) Bone formation pathways He leads an active research laboratory, further detailed on his lab site.

• Infectious Diseases
• Neuroinfectious Diseases
• Meningitis Research
• +۳ مورد دیگر

Niels Obel is a Clinical Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, specializing in Internal Medicine with a focus on infection medicine. His work significantly contributes to understanding neurological complications of infectious diseases and long-term outcomes in patients. Professor Obel's primary research interests include: Neuroinfectious diseases, particularly meningitis (bacterial, viral, and enteroviral) Pediatric infectious diseases and their long-term neurological consequences HIV/AIDS epidemiology and associated complications Population-based cohort studies using Danish national health registries His recent publications demonstrate a strong focus on nationwide epidemiological studies examining neurological disorders following various types of meningitis in children, associations between neuroborreliosis and psychiatric conditions, and cancer risks in HIV-positive populations. Professor Obel frequently collaborates with major Danish research institutions and hospitals on large-scale infectious disease research. Professor Obel maintains an active clinical research program with over 250 publications, primarily journal articles, demonstrating his significant contributions to the field of infectious diseases. His research methodology heavily relies on Denmark's comprehensive national health registries, allowing for robust population-based studies with long follow-up periods. Based at Blegdamsvej in Copenhagen, Professor Obel works within the clinical infrastructure of the Danish healthcare system, bridging clinical practice with academic research in infectious diseases.

• Biomedical Engineering
• Electrical Engineering
• Circuit Design
• +۷ مورد دیگر

Christofer "Chris" Toumazou is a distinguished British Cypriot electronic engineer serving as the Regius Professor of Engineering at Imperial College London, a prestigious appointment made during the Queen's Diamond Jubilee in 2013. He also holds positions as Chief Scientist of the Institute of Biomedical Engineering and Professor of Circuit Design at Imperial. Beyond academia, Toumazou is an accomplished entrepreneur, having founded Toumaz Holdings Ltd and DNA Electronics Ltd., and co-founding DNAnudge, which developed the groundbreaking CovidNudge point-of-care diagnostic system. With a research portfolio spanning over 800 publications, Toumazou's work primarily focuses on the intersection of semiconductor technology and biomedical applications. His most significant contribution is the development of ISFET (Ion-Sensitive Field-Effect Transistor) technology for DNA detection, which eliminates the need for optical systems in genetic testing and enables miniaturized, lab-free diagnostic devices. This innovation has been applied across various healthcare domains including pandemic response, cancer diagnostics, and personalized medicine. Toumazou's publication record shows consistent high-impact output across biomedical engineering, electrical engineering, and applied physics. His recent work (2020-2022) has particularly emphasized point-of-care diagnostics, personalized healthcare systems integrating genetic information with real-time monitoring, and novel approaches to DNA analysis. His research demonstrates a clear trajectory from fundamental circuit design to practical healthcare applications that address significant clinical needs. Fellow of the Royal Society (FRS) Fellow of the Royal Academy of Engineering (FREng) Fellow of the Academy of Medical Sciences (FMedSci) Fellow of the Institution of Engineering and Technology (FIET) Fellow of the Institute of Electrical and Electronics Engineers (FIEEE) Regius Professor of Engineering at Imperial College London Professor Toumazou maintains an active research program with numerous ongoing projects bridging engineering and medicine. His work continues to focus on developing next-generation diagnostic technologies that integrate semiconductor electronics with biological systems, with particular emphasis on making sophisticated genetic testing accessible at the point of care. Through his academic position and entrepreneurial ventures, he maintains strong connections between fundamental research, commercial development, and clinical implementation of new healthcare technologies.

Diana Elena Bucurمشاهده پروفایل

پژوهشگر

• Plant Pathology
• Molecular Plant Pathology
• Crop Protection
• +۴ مورد دیگر

Diana Elena Bucur serves as a Postdoctoral Researcher at TEAGASC - The Agriculture and Food Development Authority within the Department of Crops, Environment & Land Use in Carlow, Ireland. Her research focuses on cereal pathology with particular emphasis on oat diseases and mycotoxin contamination in Irish agricultural systems. Previously, she completed her Master's studies at Alexandru Ioan Cuza University's Faculty of Biology in Iaşi, Romania while simultaneously working as a Research Assistant at the National Institute of Research and Development for Biological Sciences. Dr. Bucur's research interests center on plant-pathogen interactions , with specific expertise in Fusarium species affecting cereal crops, molecular detection methods for plant pathogens, and fungicide resistance mechanisms. Her work bridges fundamental molecular biology with practical agricultural applications, particularly in developing diagnostic tools for early pathogen detection and understanding mycotoxin contamination pathways. She has established herself as a specialist in oat pathology, addressing critical food safety concerns related to trichothecene mycotoxins through innovative molecular approaches. Analysis of her publication record reveals a strong progression toward increasingly sophisticated molecular methodologies, with recent work (2024-2025) focused on digital PCR applications for pathogen quantification and investigations into the complex relationship between mycotoxins and grain microbiomes. Her research demonstrates consistent collaboration with University College Dublin researchers, particularly Fiona Doohan and Steven Kildea, indicating integration within Ireland's agricultural research network. Dr. Bucur's scientific contributions have generated 1,294 reads and 44 citations across her 12 publications on ResearchGate, reflecting growing recognition in the plant pathology community. Her work addresses timely agricultural challenges, particularly relevant given the 2024 EU regulation tightening limits for T2 and HT-2 toxins in oats. Her research program operates within TEAGASC's cereal pathology framework, collaborating with national and international partners to develop practical solutions for Irish farmers while contributing to fundamental understanding of plant-pathogen interactions. Current projects appear focused on improving detection methods for symptomless infections and understanding the ecological factors influencing mycotoxin production in cereal grains.